![](https://images.squarespace-cdn.com/content/v1/652d174a785a5942a5b5373a/480acff6-fc06-4654-bbfa-4d330d8ad289/The-Pharma-Navigator-News.png)
Featured Stories
Aizon Secures $20M for AI-Based Pharma Manufacturing & Next-Gen Electronic Batch Record Systems
Aizon has raised $20 million in Series C financing, with NewVale Capital leading the round with support from current backers. This funding boost is set to advance their AI-based platform for pharmaceutical manufacturing and aid in deploying their latest electronic batch record (eBR) system.
Getting Your Molecule Thru the Clinic in these Challenging Times – a View from your CDMO Partners
Sponsored by Expert Insights and Orientation Marketing, a panel of senior executives from the development and manufacturing partners charged with scaling and supplying medicines to patients were optimistic about 2024, but reflected on some of the challenges the industry will face too.
Panel: Getting Your Molecule Thru the Clinic in these Challenging Times- a View from Partners’ C-Suite
Brought to you by Orientation Marketing, hear thought-provoking views from five experienced c-level executives from leading development, technology, manufacturing, and bioprocessing partners.
Unlocking AI’s Potential in Pharma
The transformative impact of Artificial Intelligence (AI) on life sciences is indisputable. Join us on an exploration of AI’s potential within the pharmaceutical and healthcare industry. Hear two thought leaders discuss AI as a catalyst to create a more efficient and accessible healthcare future.